Skip to main content

UBS Group AG

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1610520 ZURICH, V8

Position in KNSA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,888,876
-$467,178 QoQ
Shares Held
45,174
-35.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. KNSA ranks #30 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,888,876 45,174
2026-03-31 $3,356,054 69,700
2025-12-31 $3,214,034 77,916
2025-09-30 $1,934,393 49,817
2025-06-30 $847,143 30,616
2025-03-31 $1,110,254 49,989
2024-12-31 $1,159,068 58,598
2024-09-30 $1,237,179 49,507